BREAKING NEWS
Let truth come out: Kharge on Oppn demand for discussion, JPC on Adani issue
IT employee, lover arrested in murder of Kochi woman
IPL Auction 2025 | GT buy Washington Sundar for Rs 3.20 crore; Shaw, Shardul go unsold
Virat Kohli doesn’t need our support, but we need the support of Kohli: Bumrah
INDIA bloc seeking JPC probe into Adani ‘scam’, govt scared of debate: Congress after LS, RS adjourned
Ranbir on criticism for doing ‘Sanju’, ‘Animal’: Important to dabble in different genres, characters
No ‘formula’ under discussion for CM’s post: Ajit Pawar
Perth Test: Bumrah leads India to its biggest Test win on Australian soil
MNS at risk of losing recognition, symbol after drawing blank in Maharashtra polls
Perth Test, Day 4: Siraj removes Smith as Australia go into lunch at 104 for five
Sambhal violence toll rises to four; prohibitory orders issued, outsiders’ entry barred till Nov 30
Two highway robbers shot at in Hubballi during spot inspection
Ullal: Auto-rickshaw accident near Konaje claims driver’s life
IPL 2025 | Got someone who can do captaincy job: Ricky Ponting on Shreyas Iyer
Will review INDI alliance’s dismal performance in Maharashtra, says Tejashwi Yadav
Dr Reddy’s Laboratories launches generic version of fesoterodine fumarate tablets in US
PTI, Jul 8, 2022, 8:15 PM IST
New Delhi: Dr Reddy’s Laboratories Ltd on Friday said it has launched its generic version of fesoterodine fumarate extended-release tablets used for treating overactive bladder in the US market.
The launch follows the approval granted by the US Food and Drug Administration (USFDA), the pharma company said in a regulatory filing.
The company’s fesoterodine fumarate extended-release tablets are available in 4 mg and 8 mg tablets, each in bottle count sizes of 30. These are the therapeutic generic equivalent of Toviaz, it added.
Citing IQVIA data, Dr Reddy’s said the Toviaz brand had US sales of approximately USD 211 million for the most recent 12 months ended May 2022.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Study links overthinking to ‘constant communication’ between brain’s fear-centre, social behaviour
Mangaluru: Campco opposes WHO’s claim of arecanut being carcinogenic
10 month baby gets new heart, new life
World COPD Day: Know your lung function
As Delhi chokes with dangerous pollution levels, doctors warn of health risks for all
MUST WATCH
Latest Additions
Wanted to kill Ajmal Kasab who caused so much of pain, recalls 26/11 terror attack victim
Two retired revenue officials among four arrested in land grabbing case in Jammu
Kerala govt to revise manual for junior doctors, house surgeons
State can interfere with religious practices if they impede development, equality rights: SC
Four cheers at MP’s Kuno park; cheetah Neerva gives birth to cub quartet
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.